You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指隨美股期貨漲逾百點 石藥/復星醫藥/藥明/歌禮製藥漲4%-12%
阿思達克 11-07 15:44

醫藥板塊今天普遍跑贏大市,先後獲高盛及光大證券重申「買入」分別升價至25.8元及維持看23.1元的石藥集團(01093.HK)再探頂,最高見21.6元,創逾15個月高,現造21.5元,續升4.9%,為最強藍籌,成交增至4,277萬股。

復星醫藥(02196.HK)高見24.3元,暫受制牛熊線(24.4元),現造23.65元,回升4.6%。聯邦制藥(03933.HK)升約4%報4.8元,創兩個月高;藍籌中生製藥(01177.HK)續升2.2%報12.1元。

上周趁高以折讓逾8%每股8.5元「抽水」的藥明生物(02269.HK)由逾16個月高位回落,今早考驗20天線(84.4元),低見84.2元獲承接,掉頭重越10天線(87.1元),報88.3元,彈4.1%。

歌禮製藥-B(01672.HK)回落至10及50天線附近獲承接,今天買盤重現,股價高見4.04元,創逾兩個月高,現造3.94元,漲12%,成交急增至1,224萬股,為一年罕見。

據內地媒體引述商務部發言人高峰指中美同意隨協議進展分階段取消加徵關稅。美股期貨於本港時間3點過後由之前牛皮偏軟,全面抽升0.4%-0.5%,道指期貨最高見27,598紀錄高,現造27,560,回升130點或0.5%。港股也由今早最低位27,534,抽升至27,900,創逾三個月高,現造27,804,續升115點或0.4%,成交額664億元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account